Pulmonx Corporation (LUNG)
NASDAQ: LUNG
· Real-Time Price · USD
2.60
-0.09 (-3.53%)
At close: Jun 25, 2025, 2:47 PM
-3.53% (1D)
Bid | 2.59 |
Market Cap | 104.67M |
Revenue (ttm) | 87.47M |
Net Income (ttm) | -57.09M |
EPS (ttm) | -1.44 |
PE Ratio (ttm) | -1.81 |
Forward PE | -1.85 |
Analyst | Buy |
Ask | 2.61 |
Volume | 92,366 |
Avg. Volume (20D) | 383,987 |
Open | 2.68 |
Previous Close | 2.69 |
Day's Range | 2.57 - 2.69 |
52-Week Range | 2.51 - 9.37 |
Beta | 0.52 |
About LUNG
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LUNG
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LUNG stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Pulmonx Corporation is scheduled to release its earnings on Jul 30, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-21.95%
Pulmonx shares are trading lower after the company...
Unlock content with
Pro Subscription
4 months ago
+32.23%
Pulmonx shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY25 sales guidance above estimates.